Literature DB >> 29237637

Underuse of anticoagulation therapy for atrial fibrillation: Are we failing our patients?

Nicholas R Jones1, F D Richard Hobbs2, Clare J Taylor3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29237637      PMCID: PMC5729145     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  11 in total

1.  Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians.

Authors:  Melina Gattellari; John Worthington; Nicholas Zwar; Sandy Middleton
Journal:  Stroke       Date:  2007-11-29       Impact factor: 7.914

2.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Authors:  Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas
Journal:  Eur Heart J       Date:  2016-08-27       Impact factor: 29.983

3.  'Rules of thumb' or reflective practice? Understanding senior physicians' decision-making about anti-thrombotic usage in atrial fibrillation.

Authors:  N Anderson; R Fuller; N Dudley
Journal:  QJM       Date:  2007-03-27

4.  Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis.

Authors:  Niteesh K Choudhry; Geoffrey M Anderson; Andreas Laupacis; Dennis Ross-Degnan; Sharon-Lise T Normand; Stephen B Soumerai
Journal:  BMJ       Date:  2006-01-10

Review 5.  Underuse of oral anticoagulants in atrial fibrillation: a systematic review.

Authors:  Isla M Ogilvie; Nick Newton; Sharon A Welner; Warren Cowell; Gregory Y H Lip
Journal:  Am J Med       Date:  2010-07       Impact factor: 4.965

6.  Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.

Authors:  Eduard Shantsila; Andreas Wolff; Gregory Y H Lip; Deirdre A Lane
Journal:  Br J Gen Pract       Date:  2015-01       Impact factor: 5.386

Review 7.  Are the novel anticoagulants better than warfarin for patients with atrial fibrillation?

Authors:  Colleen M Hanley; Peter R Kowey
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

8.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

9.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

10.  Under-prescribing of Prevention Drugs and Primary Prevention of Stroke and Transient Ischaemic Attack in UK General Practice: A Retrospective Analysis.

Authors:  Grace M Turner; Melanie Calvert; Max G Feltham; Ronan Ryan; David Fitzmaurice; K K Cheng; Tom Marshall
Journal:  PLoS Med       Date:  2016-11-15       Impact factor: 11.069

View more
  3 in total

1.  GPs' understanding of the benefits and harms of treatments for long-term conditions: an online survey.

Authors:  Julian Stephen Treadwell; Geoff Wong; Coral Milburn-Curtis; Benjamin Feakins; Trisha Greenhalgh
Journal:  BJGP Open       Date:  2020-05-01

2.  Prescribing at 95 years of age: cross-sectional findings from the Newcastle 85+ study.

Authors:  Laurie E Davies; Andrew Kingston; Adam Todd; Barbara Hanratty
Journal:  Int J Clin Pharm       Date:  2022-07-30

Review 3.  Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review.

Authors:  Magnolia Cardona; Louise Craig; Mark Jones; Oyungerel Byambasuren; Mila Obucina; Laetitia Hattingh; Justin Clark; Paul Glasziou; Tammy Hoffmann
Journal:  Glob Heart       Date:  2022-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.